Thr65
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr65  -  MARK1 (human)

Site Information
AMBIGUOUS SITES: MARK2 (human): , MARK3 (human): , MARK4 (human):
GNYRLQKtIGkGNFA   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 7447314

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 )
Relevant cell line - cell type - tissue:
HCT116 (intestinal) ( 2 ) , HeLa_Meta (cervical) ( 1 ) , HeLa_Pro (cervical) ( 1 ) , HeLa_Telo (cervical) ( 1 )

Upstream Regulation
Treatments:
MG132_withdrawal ( 1 )

References 

1

Dulla K, et al. (2010) Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression. Mol Cell Proteomics 9, 1167-81
20097925   Curated Info

2

Oppermann FS, et al. (2009) Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 8, 1751-64
19369195   Curated Info